Publication | Closed Access

Cinobufacini retards progression of pancreatic ductal adenocarcinoma through targeting YEATS2/TAK1/NF-κB axis

Tumor BiologyCinobufacini Retards ProgressionPancreatic CancerGastrointestinal OncologyMedicineImmunologyPathologyCancer Cell BiologyCancer BiologyPancreatic Ductal AdenocarcinomaCancer GeneticsOncologyYeats2/tak1/nf-κb AxisCancer Research